REQUEST A DEMO
Total
USD $0.00
Search more companies

Salus Pharma Labs Sas (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Salus Pharma Labs Sas Profile Updated: April 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Salus Pharma Labs Sas is based in Colombia, with the head office in Bogota D.C.. The company operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on June 30, 2009. 164 (2026) employees currently work for Salus Pharma Labs Sas. From the latest financial highlights, Salus Pharma Labs Sas reported a net sales revenue drop of 28.2% in 2025. There was a total growth of 12.78% in Salus Pharma Labs Sas’s total assets over the same period. In 2025, Salus Pharma Labs Sas’s net profit margin increased by 5.18%.

Headquarters
Cra 57 # 70 C 29
Bogota D.C.; Bogota D.C; Postal Code: 0223

Contact Details: Purchase the Salus Pharma Labs Sas report to view the information.

Basic Information
Total Employees:
Purchase the Salus Pharma Labs Sas report to view the information.
Financial Auditors:
Purchase the Salus Pharma Labs Sas report to view the information.
Incorporation Date:
June 30, 2009
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Salus Pharma Labs Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-28.2%
Total Operating Revenue
-28.2%
Operating Profit
3.29%
Net Profit/Loss for the Period
151.88%
Total Assets
12.78%
Total Equity
12.92%
Operating Profit Margin
1.47%
Net Profit Margin
5.18%
Return on Equity (ROE)
6.84%
Quick Ratio
-0.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?